학술논문

Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability
Document Type
article
Source
Stem Cell Reports. 7(3)
Subject
Biochemistry and Cell Biology
Biological Sciences
Alzheimer's Disease Related Dementias (ADRD)
Acquired Cognitive Impairment
Stem Cell Research - Induced Pluripotent Stem Cell - Human
Frontotemporal Dementia (FTD)
Dementia
Alzheimer's Disease
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Stem Cell Research - Induced Pluripotent Stem Cell
Aging
Neurodegenerative
Neurosciences
Stem Cell Research
Brain Disorders
Rare Diseases
Aetiology
2.1 Biological and endogenous factors
Neurological
Amino Acid Substitution
Autophagy
Biomarkers
Cell Differentiation
Cell Line
Codon
Frontotemporal Dementia
Gene Expression Regulation
Humans
Induced Pluripotent Stem Cells
Mutation
Neural Stem Cells
Neurons
Protein Isoforms
Protein Processing
Post-Translational
Stress
Physiological
tau Proteins
Clinical Sciences
Biochemistry and cell biology
Language
Abstract
Frontotemporal dementia (FTD) and other tauopathies characterized by focal brain neurodegeneration and pathological accumulation of proteins are commonly associated with tau mutations. However, the mechanism of neuronal loss is not fully understood. To identify molecular events associated with tauopathy, we studied induced pluripotent stem cell (iPSC)-derived neurons from individuals carrying the tau-A152T variant. We highlight the potential of in-depth phenotyping of human neuronal cell models for pre-clinical studies and identification of modulators of endogenous tau toxicity. Through a panel of biochemical and cellular assays, A152T neurons showed accumulation, redistribution, and decreased solubility of tau. Upregulation of tau was coupled to enhanced stress-inducible markers and cell vulnerability to proteotoxic, excitotoxic, and mitochondrial stressors, which was rescued upon CRISPR/Cas9-mediated targeting of tau or by pharmacological activation of autophagy. Our findings unmask tau-mediated perturbations of specific pathways associated with neuronal vulnerability, revealing potential early disease biomarkers and therapeutic targets for FTD and other tauopathies.